Millipore Sigma Vibrant Logo

407256 IGF-II, CF, Mouse, Recombinant

IGF-II, CF, Mouse, Recombinant : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Multiplication-stimulating polypeptide Somatomedin A

View Products on Sigmaaldrich.com
407256
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

Purity
≥97% by SDS-PAGE

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
407256-50UG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Flacon en verre 50 μg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewRecombinant, mouse insulin-like growth factor II (IGF-II) consisting of amino acids 25-91 and expressed in E. coli. Mouse IGF-II is synthesized as a 180 amino acid preproprecursor. Mature IGF-II is 91% and 97% amino acid identical to human and rat IGF-II, respectively.
      Catalogue Number407256
      Brand Family Calbiochem®
      SynonymsMultiplication-stimulating polypeptide Somatomedin A
      References
      ReferencesOstrovsky, O., et al. 2009. Mol. Biol. Cell 20, 1855.
      Chao, W. & P. A. DAmore, 2008. Cytokine Growth Factor Rev. 19, 111.
      Belfiore, A., 2007. Curr. Pharm. Des. 13, 671.
      Cornish, J., et al. 2007. Am. J. Physiol. Endocrinol. Metab. 292,E117.
      Merrick, D., et al. 2007. BMC Dev. Biol. 7, 65.
      Pavelic, J., et al. 2007. Indian J. Med. Res. 125, 511.
      VarelaNieto, I., et al. 2007. Curr. Pharm. Des. 13,687.
      Denley, A. et al. 2005. Cytokine Growth Factor Re,v. 16, 421.
      LeRoith, D. & C.T. Roberts Jr., 2003. Cancer Lett. 195,127.
      Buchanan, C.M., et al. 2001. Biochem. J. 360, 431.
      Werner, H. & D. LeRoith, 2000. Cell. Mol. Life Sci. 57, 932.
      Goya, L., et al. 1999. J. Biol. Chem. 274 24633.
      Daughaday, W.H., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 5823.
      Holthuizen, P.E., et al. 1993. Regul. Pept. 48, 77.
      McCarthy, T.L., et al. 1992. Endocrinology 130, 1303.
      Zindy, F., et al. 1992. J. Hepatol. 14, 30.
      Rotwein, P. & L.J. Hall, 1990. DNA Cell Biol. 10,725.
      Rotwein, P., et al. 1988. Proc. Natl. Acad. Sci. USA 85, 265.
      Stempien, M.M., et al. 1986. DNA 5, 357.
      Product Information
      FormSolid
      FormulationLyophilized from 0.2 µm sterile-filtered Acetonitrile, TFA.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityED₅₀ = 2-10 ng/ml as measured in a serum-free cell proliferation assay using MCF-7 human breast adenocarcinoma cells.
      Purity≥97% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      407256-50UG 04055977188745

      Documentation

      IGF-II, CF, Mouse, Recombinant FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      IGF-II, CF, Mouse, Recombinant Certificats d'analyse

      TitreNuméro de lot
      407256

      Références bibliographiques

      Aperçu de la référence bibliographique
      Ostrovsky, O., et al. 2009. Mol. Biol. Cell 20, 1855.
      Chao, W. & P. A. DAmore, 2008. Cytokine Growth Factor Rev. 19, 111.
      Belfiore, A., 2007. Curr. Pharm. Des. 13, 671.
      Cornish, J., et al. 2007. Am. J. Physiol. Endocrinol. Metab. 292,E117.
      Merrick, D., et al. 2007. BMC Dev. Biol. 7, 65.
      Pavelic, J., et al. 2007. Indian J. Med. Res. 125, 511.
      VarelaNieto, I., et al. 2007. Curr. Pharm. Des. 13,687.
      Denley, A. et al. 2005. Cytokine Growth Factor Re,v. 16, 421.
      LeRoith, D. & C.T. Roberts Jr., 2003. Cancer Lett. 195,127.
      Buchanan, C.M., et al. 2001. Biochem. J. 360, 431.
      Werner, H. & D. LeRoith, 2000. Cell. Mol. Life Sci. 57, 932.
      Goya, L., et al. 1999. J. Biol. Chem. 274 24633.
      Daughaday, W.H., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 5823.
      Holthuizen, P.E., et al. 1993. Regul. Pept. 48, 77.
      McCarthy, T.L., et al. 1992. Endocrinology 130, 1303.
      Zindy, F., et al. 1992. J. Hepatol. 14, 30.
      Rotwein, P. & L.J. Hall, 1990. DNA Cell Biol. 10,725.
      Rotwein, P., et al. 1988. Proc. Natl. Acad. Sci. USA 85, 265.
      Stempien, M.M., et al. 1986. DNA 5, 357.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision21-Sepmtember-2011 RFH
      SynonymsMultiplication-stimulating polypeptide Somatomedin A
      DescriptionRecombinant, mouse insulin-like growth factor II (IGF-II) consisting of amino acids 25-91 and expressed in E. coli. Mouse IGF-II is synthesized as a 180 amino acid preproprecursor. Mature IGF-II is 91% and 97% amino acid identical to human and rat IGF-II, respectively.
      FormSolid
      FormulationLyophilized from 0.2 µm sterile-filtered Acetonitrile, TFA.
      Purity≥97% by SDS-PAGE
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Biological activityED₅₀ = 2-10 ng/ml as measured in a serum-free cell proliferation assay using MCF-7 human breast adenocarcinoma cells.
      SolubilityReconstitute to 100 µg/ml in sterile PBS.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesOstrovsky, O., et al. 2009. Mol. Biol. Cell 20, 1855.
      Chao, W. & P. A. DAmore, 2008. Cytokine Growth Factor Rev. 19, 111.
      Belfiore, A., 2007. Curr. Pharm. Des. 13, 671.
      Cornish, J., et al. 2007. Am. J. Physiol. Endocrinol. Metab. 292,E117.
      Merrick, D., et al. 2007. BMC Dev. Biol. 7, 65.
      Pavelic, J., et al. 2007. Indian J. Med. Res. 125, 511.
      VarelaNieto, I., et al. 2007. Curr. Pharm. Des. 13,687.
      Denley, A. et al. 2005. Cytokine Growth Factor Re,v. 16, 421.
      LeRoith, D. & C.T. Roberts Jr., 2003. Cancer Lett. 195,127.
      Buchanan, C.M., et al. 2001. Biochem. J. 360, 431.
      Werner, H. & D. LeRoith, 2000. Cell. Mol. Life Sci. 57, 932.
      Goya, L., et al. 1999. J. Biol. Chem. 274 24633.
      Daughaday, W.H., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 5823.
      Holthuizen, P.E., et al. 1993. Regul. Pept. 48, 77.
      McCarthy, T.L., et al. 1992. Endocrinology 130, 1303.
      Zindy, F., et al. 1992. J. Hepatol. 14, 30.
      Rotwein, P. & L.J. Hall, 1990. DNA Cell Biol. 10,725.
      Rotwein, P., et al. 1988. Proc. Natl. Acad. Sci. USA 85, 265.
      Stempien, M.M., et al. 1986. DNA 5, 357.